- Novo Nordisk (NVO) shares fell after CEO Mike Doustdar disappointed investors looking for concrete turnaround plans following the company's loss of leadership in the obesity market to Eli Lilly.
- Novo Nordisk pledged to launch more than five blockbusters and deliver more than $23 billion in new sales in coming years.
- Accenture (ACN) shares rose on news that Anthropic is partnering with Accenture to test the safety of its advanced artificial intelligence models.
- Arhaus (ARHS) moved after Jefferies upgraded the furniture company to buy from hold, citing newfound optimism on brand awareness and market share.
Quotes
“investors are selling shares due to lack of concrete news”
“newfound optimism on the retailer’s strategy to elevate brand awareness”